Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets

Dendritic cell (DC)-based immunotherapy employs the patients’ immune system to fight neoplastic lesions spread over the entire body. This makes it an important therapy option for patients suffering from metastatic melanoma, which is often resistant to chemotherapy. However, conventional cellular vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Wimmers, Florian, Schreibelt, Gerty, Sköld, Annette E., Figdor, Carl G., De Vries, I. Jolanda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990057/
https://www.ncbi.nlm.nih.gov/pubmed/24782868
http://dx.doi.org/10.3389/fimmu.2014.00165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990057/
https://www.ncbi.nlm.nih.gov/pubmed/24782868
http://dx.doi.org/10.3389/fimmu.2014.00165

Ejemplares similares